TIME TO ACCESS ORPHAN MEDICINES IN GREECE

被引:0
|
作者
Chantzaras, A. [1 ]
Margetis, A. [1 ]
Kani, C. [1 ]
Koutsiouris, V [2 ]
Bacopoulou, F. [1 ]
机构
[1] Hlth Technol Assessment & Reimbursement Comm, Athens, Greece
[2] Hellen Minist Hlth, Athens, Greece
关键词
D O I
暂无
中图分类号
F [经济];
学科分类号
02 ;
摘要
HTA173
引用
收藏
页码:S352 / S352
页数:1
相关论文
共 50 条
  • [41] TITLE: ACCESS TO ORPHAN AND ULTRA-ORPHAN DRUGS IN CHINA
    Gambari, J.
    Yang, M.
    Chowdhury, C. A.
    Duttagupta, S.
    VALUE IN HEALTH, 2016, 19 (07) : A826 - A826
  • [42] Orphan Drugs for Rare Diseases Is it Time to Revisit Their Special Market Access Status?
    Simoens, Steven
    Cassiman, David
    Dooms, Marc
    Picavet, Eline
    DRUGS, 2012, 72 (11) : 1437 - 1443
  • [43] Regulate access to medicines
    Mignot, Leo
    REVUE FRANCAISE DE SOCIOLOGIE, 2022, 63 (3-4): : 607 - 611
  • [44] Access to new medicines
    Ramasubbu, Rajamannar
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2011, 56 (07):
  • [45] Access to medicines for children
    Vardanyan, L.
    Kazaryan, I.
    Sevikyan, A.
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2021, 31
  • [46] Access to medicines in France
    Bouvenot, Gilles
    Bouvenot, Julien
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2009, 193 (03): : 649 - 659
  • [47] Increasing access to medicines
    Finch, Roger
    Garner, Sarah
    BRITISH MEDICAL JOURNAL, 2009, 338
  • [48] Access to Novel Medicines
    不详
    JOURNAL OF CARDIOVASCULAR NURSING, 2018, 33 (02) : 96 - 97
  • [49] Methylphenidate denied access to the WHO List of Essential Medicines for the second time
    Ribeiro, Johanne Pereira
    Lunde, Charlotte
    Gluud, Christian
    Simonsen, Erik
    Storebo, Ole Jakob
    BMJ EVIDENCE-BASED MEDICINE, 2023, 28 (02) : 75 - 77
  • [50] Orphan Medicines for Pediatric Use: A Focus on the European Union
    Bolislis, Winona Rei
    Corriol-Rohou, Solange
    Hill-Venning, Claire
    Hoogland, Hans
    Joos, Angelika
    King, David
    Kitcatt, Victoria
    Le Visage, Genevieve
    Kuhler, Thomas C.
    CLINICAL THERAPEUTICS, 2019, 41 (12) : 2630 - 2642